Krishna B Singh

5PUBLICATIONS
12CO-AUTHORS
Innate immunityMolecular targetsBiologically active moleculesCancer therapy (excl. chemotherapy and radiation therapy)
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|May 04, 2026
Oral Administration of Withaferin A Increases Infiltration of CD4<sup>+</sup> Helper T Cells in a Mouse Model of Mammary Tumor.

|Mar 19, 2026
Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax on Fatty Acid Synthesis in Prostate Cancer.

Eun-Ryeong Hahm, Bruce L Jacobs, Krishna B Singh

|Feb 25, 2026
Bench-to-Bedside Evaluation of Sulforaphane/BroccoMax® on Fatty Acid Synthesis in Prostate Cancer.

Eun-Ryeong Hahm, Bruce L Jacobs, Krishna B Singh

|Oct 17, 2022
Withaferin A Inhibits Fatty Acid Synthesis in Rat Mammary Tumors.

Krishna B Singh, Eun-Ryeong Hahm, Su-Hyeong Kim

|Apr 09, 2020
Diallyl Trisulfide Inhibits Leptin-induced Oncogenic Signaling in Human Breast Cancer Cells but Fails to Prevent Chemically-induced Luminal-type Cancer in Rats.

Su-Hyeong Kim, Eun-Ryeong Hahm, Krishna B Singh

Pageof 1

Frequent Collaborators

5 joint publications

Eun-Ryeong Hahm

5 joint publications

Shivendra V Singh

4 joint publications

Su-Hyeong Kim

2 joint publications

Bruce L Jacobs